Mellon Medical BV

Mellon Medical BV

Mellon Medical BV

Date Founded



Transistorweg 5,Nijmegen, Gelderland 6534 AT

Type of Company


Employees (Worldwide)

1 - 10


Medical Products & Equipment
Medical Support Services
Industrial Machinery & Manufacturing
Hospitals & Patient Services
Holding Companies

Company Description

Mellon Medical BV manufactures and develops surgical suturing devices. The firm’s suturing device, the Switch, is designed for surgeons who perform the challenging operations and can easily be rotated in the hand because of its pencil-like shape. The company was founded in April 2013 by Mark Vrancken Peeters and is headquartered in Nijmegen, the Netherlands.

Board of Directors

Partner at Biogeneration Management BV

Paths to Mellon Medical BV
Potential Connections via
Relationship Science
Mellon Medical BV
Details Hidden

Ontwikkelingsmaatschappij Oost Nederland NV is an active manager that invests in a variety of sectors, such as renewable energy, health and miscellaneous. It seeks to invest in start ups located in the east of The Netherlands. It generally considers co-investments.

Details Hidden

Biogeneration Management's investment approach aims to fill the funding gap for start-up and early-stage firms involved in the life sciences sector, including applications in pharmaceuticals, agriculture, food and industrial biotechnology. They have invested in specific areas such as vaccines based on proprietary adjuvant and carrier technology, molecular diagnostics and research in biomarkers for GU cancer, and osteoinductive materials for clinical application in-bone regenerative surgery.The firm seeksto identify the potential value in prospective investee firms and will supply the missing expertise or skills through their in-house resources or external networks.Biogeneration Management invests in both public and private firms based The Netherlands. They seek technologies and development strategies within the life sciences sector which have clear paths to market and commercialization prospects. The investment team works closely with their investee firms to formulate the optimal growth strategy, to launch business development, to support clinical planning and to assist with the formulation of business plans for additional rounds of financing. Together, they define a clear exit strategy and establish milestones.

Details Hidden

TCM's investment objective is to achieve superior return. Their investment strategy focuses on private, early-stage firms active in the healthcare/life science sector with a particular concentration on biotechnology, biopharmaceutical and medical innovations. They look for start-up and early-stage firms in the Benelux region.TCM takes both lead investor and co-investor roles. As co-investor, they prefer to associate with an international syndicate of venture capital investors. The target fund size is EUR 50 million.TCM is an active, hands-on investment partner. They strive to develop close working relationships with the management teams of their portfolio firms to realize strategic objectives. They seek to grow the businesses through capital injection and by providing access to their wide networks composed of industry and private equity professionals.Key investment criteria they look for include new technologies or products, superior commercialization prospects in either large or niche markets, experienced management teams with a clear strategy, sustainable business plan founded on a robust IP portfolio as well as clearly articulated development milestones.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Mellon Medical BV. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Mellon Medical BV's profile does not indicate a business or promotional relationship of any kind between RelSci and Mellon Medical BV.